These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests. Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM. J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985 [Abstract] [Full Text] [Related]
3. The in vitro activity and beta-lactamase stability of cefpiramide compared with other beta-lactam antibiotics. Neu HC, Chin NX. Diagn Microbiol Infect Dis; 1985 Nov; 3(6):479-88. PubMed ID: 3877607 [Abstract] [Full Text] [Related]
5. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics. Neu HC, Chin NX, Labthavikul P. J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100 [Abstract] [Full Text] [Related]
6. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Fuchs PC, Jones RN, Barry AL, Thornsberry C. Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316 [Abstract] [Full Text] [Related]
10. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM. J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [Abstract] [Full Text] [Related]
12. In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and beta-lactamase studies. Jones RN, Wilson HW, Thornsberry C, Barry AL. Diagn Microbiol Infect Dis; 1985 Nov; 3(6):489-99. PubMed ID: 2998694 [Abstract] [Full Text] [Related]
13. In vitro studies with Bay V 3522, a new oral cephalosporin. Thomson KS, Sanders CC, Sanders WE. Drugs Exp Clin Res; 1991 Nov; 17(3):165-73. PubMed ID: 1914843 [Abstract] [Full Text] [Related]
15. In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China. Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M. J Infect Chemother; 2000 Jun; 6(2):81-5. PubMed ID: 11810540 [Abstract] [Full Text] [Related]
16. Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability. Barry AL, Jones RN, Thornsberry C, Ayers LW, Kundargi R. Diagn Microbiol Infect Dis; 1985 Mar; 3(2):93-104. PubMed ID: 3872196 [Abstract] [Full Text] [Related]
17. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases. Shannon K, King A, Phillips I. J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169 [Abstract] [Full Text] [Related]
18. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics. Jones RN, Barry AL. Rev Infect Dis; 1983 Jun; 5 Suppl 1():S108-26. PubMed ID: 6221381 [Abstract] [Full Text] [Related]
19. In-vitro activity and beta-lactamase stability of SR 44337, a new long acting cephalosporin. Cooper MA, Andrews JM, Baldwin DR, Thornber D, Wise R. J Antimicrob Chemother; 1991 Aug; 28(2):229-37. PubMed ID: 1778854 [Abstract] [Full Text] [Related]
20. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination. Allan JD, Eliopoulos GM, Ferraro MJ, Moellering RC. Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875 [Abstract] [Full Text] [Related] Page: [Next] [New Search]